Technical Chemical & Products (TCPI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Technical Chemical & Products (TCPI)

TCPI 1.180

0.0%

Dec 2 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: go4it who wrote (47)	1/9/1998 11:39:00 AM
From: Andrew Abrams	Read Replies (1) of 111

Companies like this (relatively small and undercapitalized) usually align themselves with a large marketing partner ( like SmithKline) in order to make a large impact in the markets. I would expect some such relationship, if not with SmithKline, with another of the same type. As the clinicals continue, companies usuallyu bring in these potential partners to view the technology. I would imagine that this has been going on for some time with TCPI and my feeling is that they are close to making an announcement. If this happens, it will do 2 things: 1) It validates the company's technology (someone else is willing to put up money. 2) It gives the company an upfront payment, and usually continueing payments as they meet goals. When the product is ready, they have a huge marketing force behind them to spend dollars that they wouldn't have to make a big splash. Having known a number of diabetics, if this product really gets off the ground, it will have a huge impact on the Glucose monitoring market. Andy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next